N/A
Completed N=107
The Dynamics of Human Atrial Fibrillation
Atrial Fibrillation · Atrial Tachyarrhythmia
Source: ClinicalTrials.gov NCT01008722 ↗
Enrolled (actual)
107
Serious AEs
7.5%
Results posted
Feb 2017
Primary outcomePrimary: Survival Free of Atrial Fibrillation — 28; 31 participants
Summary
The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Survival Free of Atrial Fibrillation |
28; 31 | — |
| SECONDARY Termination or Slowing of Atrial Fibrillation During Ablation |
31; 13 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects will be patients undergoing electrophysiology study and ablation for paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1 anti-arrhythmic drug.
Data sourced from ClinicalTrials.gov (NCT01008722). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.